Profitability Metrics

Gross Margin
22.79%
Operating Margin
8.34%
Net Margin
-3.65%

Efficiency Metrics

Revenue per Expense Ratio
1.09
R&D as % of Revenue
0.00%

Earnings Quality

EBITDA Margin
20.92%
Income Tax Rate
268,900,000.0%
EPS
-1.1300000000

Balance Sheet Analysis

Current Ratio
1.43
Cash Ratio
1.00
Working Capital
$72.23M
Debt to Equity
1.54
Debt to Assets
54.91%
Equity Ratio
35.70%

Cash Flow Analysis

Operating Cash Flow Ratio
11.46%
Free Cash Flow Ratio
1.03%
CapEx to Revenue
10.43%
Dividends Paid
$52.56M
Stock Buybacks
$29.13M
Total Shareholder Returns
$81.69M
Cash Position Change
-47.26%

Key Takeaways (2023 FY)

  • Increased dividend payments by 167.34%

Detailed Growth Metrics

Core Performance

Revenue
10.42%
Net Income
-252.11%
EPS
-653.33%
Operating Income
-9.83%

Operational Efficiency

R&D Expenses
-100.00%
SG&A Expenses
-52.86%
Operating Cash Flow
-22.63%
Free Cash Flow
40.28%

Balance Sheet Health

Assets
-7.13%
Debt
-12.33%
Book Value per Share
4.65%
Inventory
-4.49%

Shareholder Returns

Dividends per Share
167.34%
Shares Outstanding
-5.31%

Long Term Trends

3Y Revenue/Share
67.82%
5Y Revenue/Share
-17.04%
3Y Dividend/Share
67.64%
5Y Dividend/Share
-16.10%